"Facts are a trap." That's an interesting tack to try: 'If the facts don't support your argument, then it must be the facts that are wrong...'
Here are some more 'traps' to consider:
* Revenues increasing an average of 22% per year every year since 2013 * Revenues DOUBLING in just four years (2013-2016) * 2016 financials are third-party-audited * 2017 financials being audited as we speak * RXMD board directors experienced in mergers & acquisition * Upgraded to OTCQB * Actively seeking merger/acquisition/expansion * Working to uplist to NASDAQ * Stock price undervalued by several times for a company with its fundamentals.